SAN DIEGO - Reuters reports that Illumina has signed a $17 million contract to provide the U.S. Food and Drug Administration with its MiSeq DNA sequencer to help the FDA track food-related pathogen outbreaks.
The agency will use MiSeq for whole genome analysis on products and samples of Salmonella and E. coli, according to Reuters.
Retuers notes that this deal comes just two weeks after the Center For Food Safety filed suit against FDA for alleged failure to fully enforce the Food Safety and Modernization Act.
Read the full report at Reuters.
(Source: Reuters)
Latest from Quality Assurance & Food Safety
- Director General of IICA and Senior USDA Officials Meet to Advance Shared Agenda
- EFSA and FAO Sign Memorandum of Understanding
- Ben Miller Breaks Down Federal Cuts, State Bans and Traceability Delays
- Michigan Officials Warn Recalled ByHeart Infant Formula Remains on Store Shelves
- Puratos USA to Launch First Professional Chocolate Product with Cultured Cocoa
- National Restaurant Association Announces Federal Policy Priorities
- USDA Offloads Washington Buildings in Reorganization Effort
- IDFA Promotes Andrew Jerome to VP of Strategic Communications and Executive Director of Foundation
